BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 36038104)

  • 21. Gastrointestinal tract and liver graft-versus-host disease in pediatric patients with hematopoietic progenitor cell transplantation at a tertiary care center in Mexico.
    Jaramillo-Esparza CM; Consuelo-Sánchez A; Acosta-Rodríguez-Bueno CP; Ramón-García G; Sadowinski-Pine SW; Escobar-Sánchez MA; Castorena-Villa I; Gaytán-Morales F; Vázquez-Frias R
    Rev Gastroenterol Mex (Engl Ed); 2018; 83(4):385-392. PubMed ID: 29486973
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk factors and outcomes of cytomegalovirus viremia in pediatric hematopoietic stem cell transplantation patients.
    Wu JL; Ma HY; Lu CY; Chen JM; Lee PI; Jou ST; Yang YL; Chang HH; Lu MY; Chang LY; Huang LM
    J Microbiol Immunol Infect; 2017 Jun; 50(3):307-313. PubMed ID: 26346369
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pneumatosis Intestinalis in Children With Intestinal Failure: The Result of Intestinal Stress From Enteral Feeding?
    Reppucci ML; Nolan MM; Cooper E; Gallagher LT; Diaz-Miron J; Somme S; Soden J; Gumer L; Acker SN
    J Pediatr Gastroenterol Nutr; 2023 May; 76(5):560-565. PubMed ID: 36800285
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pneumatosis intestinalis with pneumoperitoneum mimicking intestinal perforation in a patient with myelodysplastic syndrome after hematopoietic stem cell transplantation.
    Keam B; Lee JH; Oh MD; Kim I; Yoon SS; Kim BK; Park S
    Korean J Intern Med; 2007 Mar; 22(1):40-4. PubMed ID: 17427646
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pneumatosis intestinalis in children beyond the neonatal period: is it always benign?
    Abramov A; Luks VL; De Bie F; Hwang R; Allukian M; Nace GW
    Pediatr Surg Int; 2022 Mar; 38(3):399-407. PubMed ID: 34837497
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Premature cyclosporine cessation and TBI-containing conditioning regimen increase the risk of acute GvHD in children undergoing unrelated donor hematopoietic stem cell transplantation.
    Szmit Z; Kałwak K; Król A; Mielcarek-Siedziuk M; Salamonowicz M; Frączkiewicz J; Ussowicz M; Owoc-Lempach J; Gorczyńska E
    Adv Clin Exp Med; 2019 Sep; 28(9):1185-1192. PubMed ID: 31430073
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Response of 443 patients to steroids as primary therapy for acute graft-versus-host disease: comparison of grading systems.
    MacMillan ML; Weisdorf DJ; Wagner JE; DeFor TE; Burns LJ; Ramsay NK; Davies SM; Blazar BR
    Biol Blood Marrow Transplant; 2002; 8(7):387-94. PubMed ID: 12171485
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pneumatosis Intestinalis in Patients Receiving Tube Feeds.
    Cavalea AC; Heidel RE; Daley BJ; Lawson CM; Benton DA; McLoughlin JM
    Am Surg; 2017 Aug; 83(8):825-831. PubMed ID: 28822385
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HLA, GVHD, and parenteral nutrition are risk factors for hepatic complications in pediatric HSCT.
    Thorvaldson L; Remberger M; Winiarski J; Omazic B; Fischler B; Sundin M
    Pediatr Transplant; 2016 Feb; 20(1):96-104. PubMed ID: 26518451
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Pharmacokinetic and Pharmacodynamic Study of Maraviroc as Acute Graft-versus-Host Disease Prophylaxis in Pediatric Allogeneic Stem Cell Transplant Recipients with Nonmalignant Diagnoses.
    Khandelwal P; Fukuda T; Mizuno K; Teusink-Cross A; Mehta PA; Marsh RA; Kashuba ADM; Vinks AA; Davies SM
    Biol Blood Marrow Transplant; 2016 Oct; 22(10):1829-1835. PubMed ID: 27498124
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Donor-Host Lineage-Specific Chimerism Monitoring and Analysis in Pediatric Patients Following Allogeneic Stem Cell Transplantation: Influence of Pretransplantation Variables and Correlation with Post-Transplantation Outcomes.
    Llaurador G; Nicoletti E; Prockop SE; Hsu S; Fuller K; Mauguen A; O'Reilly RJ; Boelens JJ; Boulad F
    Transplant Cell Ther; 2021 Sep; 27(9):780.e1-780.e14. PubMed ID: 34082161
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low-risk pneumatosis intestinalis in the pediatric surgical population.
    Weber NT; Ogle S; Cooper EH; Kaizer AM; Kulungowski AM; Acker SN
    Pediatr Surg Int; 2024 Mar; 40(1):76. PubMed ID: 38466447
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pneumatosis intestinalis in the pediatric oncology population: An 11-year retrospective review at Memorial Sloan Kettering Cancer Center.
    Bailey KA; Kodikara H; Mauguen A; Price A; LaQuaglia M; Boulad F
    Pediatr Blood Cancer; 2022 Jul; 69(7):e29539. PubMed ID: 34962703
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mycophenolate mofetil versus methotrexate for prevention of graft-versus-host disease in people receiving allogeneic hematopoietic stem cell transplantation.
    Kharfan-Dabaja M; Mhaskar R; Reljic T; Pidala J; Perkins JB; Djulbegovic B; Kumar A
    Cochrane Database Syst Rev; 2014 Jul; 2014(7):CD010280. PubMed ID: 25061777
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Post-Transplantation Cyclophosphamide-Based Haploidentical versus Matched Unrelated Donor Peripheral Blood Hematopoietic Stem Cell Transplantation Using Myeloablative Targeted Busulfan-Based Conditioning for Pediatric Acute Leukemia.
    Hong KT; Park HJ; Kim BK; An HY; Choi JY; Kang HJ
    Transplant Cell Ther; 2022 Apr; 28(4):195.e1-195.e7. PubMed ID: 35021131
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Patterns of Genital Examination and Vulvovaginal Graft-Versus-Host Disease in a Pediatric Post-Hematopoietic Stem Cell Transplant Population.
    Allen SM; Liang CS; Chesnokova AE; Childress KJ; Pascoe KF; Dietrich JE
    J Pediatr Adolesc Gynecol; 2020 Dec; 33(6):658-666. PubMed ID: 32781233
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Outcome of Haploidentical Peripheral Blood Allografts Using Post-Transplantation Cyclophosphamide Compared to Matched Sibling and Unrelated Donor Bone Marrow Allografts in Pediatric Patients with Hematologic Malignancies: A Single-Center Analysis.
    Srinivasan A; Raffa E; Wall DA; Schechter T; Ali M; Chopra Y; Kung R; Chiang KY; Krueger J
    Transplant Cell Ther; 2022 Mar; 28(3):158.e1-158.e9. PubMed ID: 34838785
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Sclerodermatous chronic graft-versus-host disease after hematopoietic stem cell transplantation: incidence, clinical characteristics and risk factors].
    Yang H; Li ZT; Lin R; Fan ZP; Huang F; Jiang QL; Zhou HS; Liu QF; Sun J
    Nan Fang Yi Ke Da Xue Xue Bao; 2016 Jun; 36(6):807-13. PubMed ID: 27320883
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical Study of Intestinal Acute Graft-Versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation in Children].
    Wang Z; Tao F; Tang W; Nie YM; Yang L; Chen Z; Teng JX; Lu WJ; Qi SS; Xiong H
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Apr; 30(2):600-606. PubMed ID: 35396003
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Donor-recipient killer immunoglobulin like receptor (KIR) genotype matching has a protective effect on chronic graft versus host disease and relapse incidence following HLA-identical sibling hematopoietic stem cell transplantation.
    Sahin U; Dalva K; Gungor F; Ustun C; Beksac M
    Ann Hematol; 2018 Jun; 97(6):1027-1039. PubMed ID: 29549412
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.